206 related articles for article (PubMed ID: 14973368)
21. Colocalization of receptors for Shiga toxins with lipid rafts in primary human renal glomerular endothelial cells and influence of D-PDMP on synthesis and distribution of glycosphingolipid receptors.
Legros N; Pohlentz G; Runde J; Dusny S; Humpf HU; Karch H; Müthing J
Glycobiology; 2017 Oct; 27(10):947-965. PubMed ID: 28535204
[TBL] [Abstract][Full Text] [Related]
22. Modelling of the interaction of verotoxin-1 (VT1) with its glycolipid receptor, globotriaosylceramide (Gb3).
Nyholm PG; Brunton JL; Lingwood CA
Int J Biol Macromol; 1995 Jun; 17(3-4):199-204. PubMed ID: 7577818
[TBL] [Abstract][Full Text] [Related]
23. Differential tissue targeting and pathogenesis of verotoxins 1 and 2 in the mouse animal model.
Rutjes NW; Binnington BA; Smith CR; Maloney MD; Lingwood CA
Kidney Int; 2002 Sep; 62(3):832-45. PubMed ID: 12164865
[TBL] [Abstract][Full Text] [Related]
24. Structure-dependent pseudoreceptor intracellular traffic of adamantyl globotriaosyl ceramide mimics.
Saito M; Mylvaganum M; Tam P; Novak A; Binnington B; Lingwood C
J Biol Chem; 2012 May; 287(20):16073-87. PubMed ID: 22418442
[TBL] [Abstract][Full Text] [Related]
25. Cholesterol masks membrane glycosphingolipid tumor-associated antigens to reduce their immunodetection in human cancer biopsies.
Novak A; Binnington B; Ngan B; Chadwick K; Fleshner N; Lingwood CA
Glycobiology; 2013 Nov; 23(11):1230-9. PubMed ID: 23906628
[TBL] [Abstract][Full Text] [Related]
26. Verotoxin Receptor-Based Pathology and Therapies.
Lingwood C
Front Cell Infect Microbiol; 2020; 10():123. PubMed ID: 32296648
[TBL] [Abstract][Full Text] [Related]
27. Globotriaosyl ceramide receptor function - where membrane structure and pathology intersect.
Lingwood CA; Binnington B; Manis A; Branch DR
FEBS Lett; 2010 May; 584(9):1879-86. PubMed ID: 19948172
[TBL] [Abstract][Full Text] [Related]
28. Soluble adamantyl glycosphingolipid analogs as probes of glycosphingolipid function.
Lingwood C; Sadacharan S; Abul-Milh M; Mylvaganum M; Peter M
Methods Mol Biol; 2006; 347():305-20. PubMed ID: 17072019
[TBL] [Abstract][Full Text] [Related]
29. Capping and receptor-mediated endocytosis of cell-bound verotoxin (Shiga-like toxin). 1: Chemical identification of an amino acid in the B subunit necessary for efficient receptor glycolipid binding and cellular internalization.
Khine AA; Lingwood CA
J Cell Physiol; 1994 Nov; 161(2):319-32. PubMed ID: 7962116
[TBL] [Abstract][Full Text] [Related]
30. Expression of the verotoxin receptor glycolipid, globotriaosylceramide, in ovarian hyperplasias.
Arab S; Russel E; Chapman WB; Rosen B; Lingwood CA
Oncol Res; 1997; 9(10):553-63. PubMed ID: 9507533
[TBL] [Abstract][Full Text] [Related]
31. Phenylalanine 30 plays an important role in receptor binding of verotoxin-1.
Clark C; Bast D; Sharp AM; St Hilaire PM; Agha R; Stein PE; Toone EJ; Read RJ; Brunton JL
Mol Microbiol; 1996 Feb; 19(4):891-9. PubMed ID: 8820657
[TBL] [Abstract][Full Text] [Related]
32. Sphingolipid symmetry governs membrane lipid raft structure.
Quinn PJ
Biochim Biophys Acta; 2014 Jul; 1838(7):1922-30. PubMed ID: 24613791
[TBL] [Abstract][Full Text] [Related]
33. Shiga toxin binding to globotriaosyl ceramide induces intracellular signals that mediate cytoskeleton remodeling in human renal carcinoma-derived cells.
Takenouchi H; Kiyokawa N; Taguchi T; Matsui J; Katagiri YU; Okita H; Okuda K; Fujimoto J
J Cell Sci; 2004 Aug; 117(Pt 17):3911-22. PubMed ID: 15265987
[TBL] [Abstract][Full Text] [Related]
34. Apparent cooperativity in multivalent verotoxin-globotriaosyl ceramide binding: kinetic and saturation binding studies with [(125)I]verotoxin.
Peter MG; Lingwood CA
Biochim Biophys Acta; 2000 Jun; 1501(2-3):116-24. PubMed ID: 10838185
[TBL] [Abstract][Full Text] [Related]
35. Expression of Shiga toxin 2e glycosphingolipid receptors of primary porcine brain endothelial cells and toxin-mediated breakdown of the blood-brain barrier.
Meisen I; Rosenbrück R; Galla HJ; Hüwel S; Kouzel IU; Mormann M; Karch H; Müthing J
Glycobiology; 2013 Jun; 23(6):745-59. PubMed ID: 23431059
[TBL] [Abstract][Full Text] [Related]
36. Fas signaling induces raft coalescence that is blocked by cholesterol depletion in human RPE cells undergoing apoptosis.
Lincoln JE; Boling M; Parikh AN; Yeh Y; Gilchrist DG; Morse LS
Invest Ophthalmol Vis Sci; 2006 May; 47(5):2172-8. PubMed ID: 16639029
[TBL] [Abstract][Full Text] [Related]
37. Evidence for glycosphingolipid modification of the type 1 IFN receptor.
Ghislain J; Lingwood CA; Fish EN
J Immunol; 1994 Oct; 153(8):3655-63. PubMed ID: 7930586
[TBL] [Abstract][Full Text] [Related]
38. Detergent-resistant globotriaosyl ceramide may define verotoxin/glomeruli-restricted hemolytic uremic syndrome pathology.
Khan F; Proulx F; Lingwood CA
Kidney Int; 2009 Jun; 75(11):1209-1216. PubMed ID: 19212418
[TBL] [Abstract][Full Text] [Related]
39. Enhanced expression of ATP-binding cassette transporter A1 in non-rafts decreases the sensitivity of vascular endothelial cells to Shiga toxin.
Higashi N; Matsumura Y; Mizuno F; Kasahara K; Sugiura S; Mikasa K; Kita E
Microb Pathog; 2010 Oct; 49(4):141-52. PubMed ID: 20553836
[TBL] [Abstract][Full Text] [Related]
40. Role of lipid rafts in Shiga toxin 1 interaction with the apical surface of Caco-2 cells.
Kovbasnjuk O; Edidin M; Donowitz M
J Cell Sci; 2001 Nov; 114(Pt 22):4025-31. PubMed ID: 11739634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
